Viability of the Myocardium after Twenty-four-hour Heart Conservation - a Preliminary Study

Abstract

Background: Orthotopic heart transplantation following ischemic times beyond four hours is associated with increased risk of early graft failure. The use of modern myocardial preservation strategies could enable safe transplantation after long-term conservation. In this study, we tested a new myocardial protection regime in an experimental model of 24 h storage. Methods: Orthotopic heart transplantations (n = 15) were performed in a pig model. Donor hearts were flushed with Bretschneider solution, excised, and stored for 24 hours at 4 °C. During implantation, controlled reperfusions with substrate-enriched leukocyte-depleted blood cardioplegia were performed after each anastomosis. Blood cardioplegia contained 1 mmol/l of the Na⁺-H⁺-exchange inhibitor HOE 642 and 100 mg/l of adenosine. Controlled reperfusion was continued with leukocyte-depleted blood for 20 min. A microaxial pump was inserted after heart transplantation and circulatory assistance was maintained for five hours to prevent right heart failure. Results: No initial graft failure could be observed. Thirteen hearts could be weaned from extracorporeal circulation. Due to bleeding problems, kidney and lung failure only five hearts could be included in the final analysis. Hemodynamics of these hearts remained stable with epinephrine at 0.1 µg/kg/min. Myocardial oxygen consumption 20 min after start of reperfusion (5.3 ± 2.0 ml/100 g/min) did not differ significantly versus baseline (6.8 ± 2.0 ml/100 g/min). Oxygen extraction six hours after heart transplantation was also well preserved compared to baseline (58.0 ± 10.2 versus 49.2 ± 8.8 %). Histological examination six hours after transplantation using luxol fast blue staining revealed that only 1.0 % of the myocytes were irreversibly damaged. Conclusions: The data indicate full viability of the myocardium after 24 h conservation. The preservation technique described could contribute to the extension of conservation times in heart transplantation and enable transplantation of marginal donor hearts.

Key words

Heart transplantation - myocardial protection - blood cardioplegia - organ conservation

References

• 1 Reichenspurner H, Russ C, Überfuhr P, Nollert G, Schluter A, Reichart B, Klövekorn W P, Schüler S, Hetzer R, Brett W. Myocardial preservation using HTK solution for heart transplantation. A multicenter study.  Eur J Cardiothorac Surg. 1993;  7 414-419
• 2 Briganti E M, Bergin P J, Rosenfeldt F L, Esmore D S, Rabinov M. Successful long-term outcome with prolonged ischemic time cardiac allografts.  J Heart Lung Transplant. 1995;  14 840-845
• 3 Obadia J F, Girard C, Frerrara R, Chuzel M, Chassignolle J F, Dureau G. Long conservation organs in heart transplantation: postoperative results and long-term follow-up in fourteen patients.  J Heart Lung Transplant. 1997;  16 256-259
• 4 Tsai F, Marelli D, Laks H, Houston E, Sykes A, Bresson J, Friend L, Vellaca A, Burch C, Kobashigawa J. Cardiac allografts with ischemic time over 300 minutes.  J Heart Lung Transplant. 2001;  20 182
• 5 Pearl J M, Drinkwater D C, Laks H, Capouya E R, Gates R N. Leukocyte-depleted reperfusion of transplanted human hearts: A randomized, double-blind clinical trial.  J Heart Lung Transplant. 1992;  11 1082-1092
• 6 Burt J M, Copeland J G. Myocardial function after preservation for 24 hours.  J Thorac Cardiovasc Surg. 1986;  92 238-246
• 7 Wicomb W N, Hill D J, Collins G M. Twenty-four h ice storage of rabbit hearts.  J Heart Lung Transplant. 1994;  13 891-894
• 8 Martin J, Sarai K, Yoshitake M, Haberstroh J, Takahashi N, Lutter G, Beyersdorf F. Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na⁺-H⁺-exchange inhibitor HOE 642.  Eur J Cardiothorac Surg. 1998;  14 607-614
• 9 Martin J, Lutter G, Ihling C, Siepe M, Wagner S, Hilberath J, Kemper M, Sarai K, Beyersdorf F. Myocardial viability 24 hours after orthotopic heart transplantation from non-heart-beating donors. J Thorac Cardiovasc Surg 2003 (in press)
• 10 Martin J, Sarai K, Yoshitake M, Haberstroh J, Takahashi N, Lutter G, Beyersdorf F. Successful orthotopic pig heart transplantation from non-heart-beating donors.  J Heart Lung Transplant. 1999;  18 597-606
• 11 Swindle M. Porcine models in surgical research: an overview. In: Tumbleson ME, editor Swine in biomedical research. New York, London; Plenum Press 1986: 135-142
• 12 Buckberg G D. Editorial: endothelial and myocardial stunning.  J Thorac Cardiovasc Surg. 2000;  120 640-641
• 13 Hottenrott C, Maloney J, Buckberg G. Studies of the effects of ventricular fibrillation on the adequacy of regional myocardial flow.  J Thorac Cardiovasc Surg. 1974;  68 615-625
• 14 Hohlfeld T, Meyer-Kirchrath J, Vogel Y C, Schror K. Reduction of infarct size by selective stimulation of prostaglandin EP(3) receptors in the reperfused ischemic pig heart.  J Mol Cell Cardiol. 2000;  32 285-296
• 15 Rosenkranz E R, Okamoto F, Buckberg G D, Vinten-Johansen J, Robertson J M, Bugyi H. Safety of prolonged aortic clamping with blood cardioplegia.  J Thorac Cardiovasc Surg. 1984;  88 402-410
• 16 Luciani G B, Faggian G, Montalbano G, Casali G, Forni A, Chiominto B, Mazzucco A. Blood versus crystalloid cardioplegia for myocardial protection of donor hearts during transplantation: a prospective, randomized clinical trial.  J Thorac Cardiovasc Surg. 1999;  118 787-795
• 17 Duilio C, Ambrosio G, Kuppusamy P, Dipaula A, Becker L C, Zweiser J L. Neutrophils are primary source of O₂ radicals during reperfusion after prolonged myocardial ischemia.  Am J Physiol Heart Circ Physiol. 2001;  280 H2649-H2657
• 18 Vinten-Johansen J, Thourani V H, Ronson R S, Jordan J E, Zhao Z Y, Nakamura M, Velez D, Guyton R A. Broad-spectrum cardioprotection with adenosine.  Ann Thorac Surg. 1999;  68 1942-1948
• 19 Hendrikx M, Mubagwa K, Verdonck F, Overloop K, Hecke P van, Vanstapel F, Lommel A van, Verbeken E, Lauweryns J, Flameng W. New Na⁺-H⁺ exchange inhibitor HOE 642 improves postischemic function and high-energy phosphate resynthesis and reduces Ca²⁺-overload in isolated perfused rabbit heart.  Circulation. 1994;  89 2787-2798
• 20 Theroux P, Chaitman B R, Danchin N, Erhardt L, Meinertz T, Schroeder J S, Gognoni G, White H D, Willerson J T, Jessel A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial.  Circulation. 2000;  102 3032-3038